An Exploratory Multicenter, Open-label, Sequential Cohort Study to Evaluate the Preliminary Efficacy, Safety, and Pharmacokinetic Characteristics of LP-98 forInjection in Antiretroviral Therapy-Naive HIV-Infected Individuals
Latest Information Update: 03 Mar 2026
At a glance
- Drugs LP 98 (Primary)
- Indications HIV infections
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Shanxi Kangbao Biological Product
Most Recent Events
- 03 Mar 2026 New trial record